161 results on '"Ishii, Hideki"'
Search Results
2. The roles of exercise stress echocardiography for the evaluation of heart failure with preserved ejection fraction in the heart failure pandemic era.
- Author
-
Yuasa, Naoki, Harada, Tomonari, Kagami, Kazuki, Ishii, Hideki, and Obokata, Masaru
- Abstract
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly 70% of all HF and has become the dominant form of HF. The increased prevalence of HFpEF has contributed to a rise in the number of HF patients, known as the "heart failure pandemic". In addition to the fact that HF is a progressive disease and a delayed diagnosis may worsen clinical outcomes, the emergence of disease-modifying treatments such as sodium-glucose transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists has made appropriate and timely identification of HFpEF even more important. However, diagnosis of HFpEF remains challenging in patients with a lower degree of congestion. In addition to normal EF, this is related to the fact that left ventricular (LV) filling pressures are often normal at rest but become abnormal during exercise. Exercise stress echocardiography can identify such exercise-induced elevations in LV filling pressures and facilitate the diagnosis of HFpEF. Exercise stress echocardiography may also be useful for risk stratification and assessment of exercise tolerance as well as cardiovascular responses to exercise. Recent attention has focused on dedicated dyspnea clinics to identify early HFpEF among patients with unexplained dyspnea and to investigate the causes of dyspnea. This review discusses the role of exercise stress echocardiography in the diagnosis and evaluation of HFpEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Clinical features, future cardiac events, and prognostic factors following percutaneous coronary intervention in young female patients.
- Author
-
Tatami, Yosuke, Tanaka, Akihito, Ohashi, Taiki, Kubota, Ryuji, Kaneko, Shinji, Shinoda, Masanori, Uemura, Yusuke, Takagi, Kensuke, Tanaka, Miho, Umemoto, Norio, Tashiro, Hiroshi, Shibata, Naoki, Yoshioka, Naoki, Watarai, Masato, Morishima, Itsuro, Takada, Yasunobu, Shimizu, Kiyokazu, Ishii, Hideki, and Murohara, Toyoaki
- Subjects
DRUG-eluting stents ,PERCUTANEOUS coronary intervention ,PROGNOSIS ,WOMEN patients ,PROPORTIONAL hazards models ,KIDNEY diseases - Abstract
Background: The proportion of young females among the patients who undergo percutaneous coronary intervention (PCI) is relatively small, and information on their clinical characteristics is limited. This study investigated the clinical characteristics and prognostic factors for future cardiac events in young females who underwent PCI. Methods: This multicenter observational study included 187 consecutive female patients aged < 60 years who underwent PCI in seven hospitals. The primary composite endpoint was the incidence of cardiac death, nonfatal myocardial infarction, and target vessel revascularization. Results: The mean patient age was 52.1 ± 6.1 years and 89 (47.6%) had diabetes, and renal dysfunction (an estimated glomerular filtration rate < 60 mL/min/1.73 m
2 ) was observed in 38 (20.3%). During a median follow-up of 3.3 years, the primary endpoint occurred in 28 patients. The Cox proportional hazards models showed that renal dysfunction was an independent predictor for the primary endpoint (hazard ratio 3.04, 95% confidence interval 1.25–7.40, p = 0.01), as well as multivessel disease (hazard ratio 2.79, 95% confidence interval 1.12–6.93, p = 0.03). Patients with renal dysfunction had a significantly higher risk for the primary endpoint than those without renal dysfunction. Conclusions: Renal dysfunction was strongly associated with future cardiac events in young females who underwent PCI. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
4. Novel synthesis of 11C‐labeled imidazolines via Pd(0)‐mediated 11C‐carbomethoxylation using [11C]CO and arylborons.
- Author
-
Ishii, Hideki, Minegishi, Katsuyuki, Nagatsu, Kotaro, Nengaki, Nobuki, and Zhang, Ming‐Rong
- Subjects
IMIDAZOLINES ,HIGH performance liquid chromatography ,ACETATES ,QUINONE - Abstract
A labeling technique was developed for the imidazoline I2 receptor ligand 2‐(3‐fluoro‐tolyl)‐4, 5‐dihydro‐1H‐imidazole (FTIMD) using Pd(0)‐mediated 11C‐carbomethoxylation with [11C]CO, followed by imidazoline ring formation with ethylenediamine‐trimethylaluminium (EDA‐AlMe3). To achieve this, [11C]CO was passed through a methanol (MeOH) solution containing 3‐fluoro‐4‐methylphenylboronic acid (1), palladium (II) acetate (Pd [OAc]2), triphenylphosphine (PPh3), and p‐benzoquinone (PBQ). The mixture was then heated at 65°C for 5 min. EDA was introduced into the reaction mixture, and MeOH was completely evaporated at temperatures exceeding 100°C. The dried reaction mixture was combined with an EDA‐AlMe (1:1) toluene solution and heated at 145°C for 10 min. Portions of the reaction mixture were analyzed through high‐performance liquid chromatography, resulting in [11C]FTIMD with 26% (n = 2) decay‐corrected radiochemical yield (RCY). This method could be utilized for various arylborons to produce [2‐11C]imidazolines 4a–h with RCYs ranging from low to moderate. Notably, [2‐11C]benazoline was obtained with a moderate RCY of 65%. The proposed technique serves as an alternative to the Grignard method, which uses [11C]CO to generate a [2‐11C]‐labeled imidazoline ring. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Combined Prognostic Impact of Two Quick Frailty Assessments in Acute Heart Failure.
- Author
-
Oguri, Mitsutoshi, Ishii, Hideki, Fujita, Rin, Takahashi, Hiroshi, and Murohara, Toyoaki
- Subjects
HEART failure ,FRAILTY ,BONE fractures ,MORTALITY ,PROGNOSIS ,UNIVARIATE analysis - Abstract
Introduction: We aimed to investigate the prognostic impact of frailty (defined by the Study of Osteoporotic Fracture [SOF] index and the Clinical Frailty Scale [CFS]) in hospitalized patients with acute decompensated heart failure (HF). Methods: A total of 1,053 patients over 75 years of age, who were primarily admitted to hospital with a diagnosis of acute decompensated HF, were enrolled. The prognostic value of frailty by the two tools for predicting all-cause mortality was analyzed using multivariate Cox regression models. Results: The incidence of frailty was 57.1% when using the SOF index, 37.6% when using the CFS, and 23.3% when using both tools. Frailty, via the SOF index or CFS, was an independent predictor of all-cause mortality in model 1, after adjustment for significantly associated factors by univariate analysis (hazard ratio [HR] 1.38, 95% confidence interval [CI] 1.04–1.84, p = 0.027; HR 1.53, 95% CI 1.15–2.05, p = 0.003, respectively), and in model 2, after adjustment for previously reported prognostic factors (HR 1.42, 95% CI 1.07–1.89, p = 0.015; HR 1.56, 95% CI 1.17–2.07, p = 0.002, respectively). Compared to non-frail patients, frail patients via both tools had a significantly higher incidence of all-cause mortality in models 1 (adjusted HR 2.16, 95% CI 1.42−3.29, p < 0.001) and 2 (adjusted HR 2.30, 95% CI 1.51−3.50, p < 0.001). Conclusions: Combined frailty screening using the SOF index and CFS contributed to stratify the risk of mortality in patients with acute decompensated HF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Pathophysiologic and prognostic importance of cardiac power output reserve in heart failure with preserved ejection fraction.
- Author
-
Takizawa, Daiki, Harada, Tomonari, Obokata, Masaru, Kagami, Kazuki, Sorimachi, Hidemi, Yuasa, Naoki, Saito, Yuki, Murakami, Fumitaka, Naito, Ayami, Kato, Toshimitsu, Wada, Naoki, and Ishii, Hideki
- Subjects
ECHOCARDIOGRAPHY ,VENTRICULAR ejection fraction ,CONFIDENCE intervals ,CARDIAC output ,DESCRIPTIVE statistics ,RESEARCH funding ,HEART failure - Abstract
Aims Heart failure with preserved ejection fraction (HFpEF) is a syndrome characterized by multiple cardiac reserve limitations during exercise. Cardiac power output (CPO) is an index of global cardiac performance and can be estimated non-invasively by echocardiography. We hypothesized that CPO reserve during exercise would be associated with impaired cardiovascular reserve, exercise intolerance, and adverse outcomes in HFpEF. Methods and results Exercise stress echocardiography was performed in 425 dyspnoeic patients [217 HFpEF and 208 non-heart failure (HF) controls] to estimate CPO at rest and during exercise. We classified patients with HFpEF based on the median value of changes in CPO from rest to peak exercise (ΔCPO >0.49 W/100 g). Patients with HFpEF and a lower CPO reserve had poorer biventricular systolic function, impaired chronotropic response during exercise, and worse aerobic capacity than controls and those with a higher CPO reserve. During a median follow-up of 358 days, a composite outcome of all-cause mortality or HF events occurred in 30 patients. Patients with a lower CPO reserve had four-fold and nearly 10-fold increased risks of the outcomes compared with those with a higher CPO reserve and controls, respectively [hazard ratio (HR) 4.05, 95% confidence interval (CI) 1.16–10.1, P = 0.003 and HR 9.61, 95% CI 3.58–25.8, P < 0.0001]. We further found that a lower CPO reserve had an incremental prognostic value over the H
2 FPEF score and exercise duration. In contrast, resting CPO did not predict clinical outcomes in patients with HFpEF. Conclusion A lower CPO reserve was associated with biventricular systolic dysfunction, chronotropic incompetence, exercise intolerance, and adverse outcomes in patients with HFpEF. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
7. Combined Prognostic Value of Preprocedural Protein–Energy Wasting and Inflammation Status for Amputation and/or Mortality after Lower-Extremity Revascularization in Hemodialysis Patients with Peripheral Arterial Disease.
- Author
-
Kumada, Yoshitaka, Kawai, Norikazu, Ishida, Narihiro, Nakamura, Yasuhito, Takahashi, Hiroshi, Ohshima, Satoru, Ito, Ryuta, Izawa, Hideo, Murohara, Toyoaki, and Ishii, Hideki
- Subjects
PERIPHERAL vascular diseases ,HEMODIALYSIS patients ,PROGNOSIS ,AMPUTATION ,TRAUMATIC amputation ,BIOMARKERS - Abstract
Protein–energy wasting is associated with inflammation and advanced atherosclerosis in hemodialysis patients. We enrolled 800 patients who had undergone successful lower-extremity revascularization, and we investigated the association among the Geriatric Nutritional Risk Index (GNRI) as a surrogate marker of protein–energy wasting, C-reactive protein (CRP), and their joint roles in predicting amputation and mortality. They were divided into lower, middle, and upper tertiles (T1, T2, and T3) according to GNRI and CRP levels, respectively. Regarding the results, the amputation-free survival rates over 8 years were 47.0%, 56.9%, and 69.5% in T1, T2, and T3 of the GNRI and 65.8%, 58.7%, and 33.2% for T1, T2, and T3 of CRP, respectively (p < 0.0001 for both). A reduced GNRI [adjusted hazard ratio (aHR) 1.78, 95% confidence interval (CI) 1.24–2.59, p = 0.0016 for T1 vs. T3] and elevated CRP (aHR 1.86, 95% CI 1.30–2.70, p = 0.0007 for T3 vs. T1) independently predicted amputation and/or mortality. When the two variables were combined, the risk was 3.77-fold higher (95% CI 1.97–7.69, p < 0.0001) in patients who occupied both T1 of the GNRI and T3 of CRP than in those who occupied both T3 of the GNRI and T1 of CRP. In conclusion, patients with preprocedurally decreased GNRI and elevated CRP levels frequently experienced amputation and mortality, and a combination of these two variables could more accurately stratify the risk. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. One‐year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J‐PCI OUTCOME registry.
- Author
-
Numasawa, Yohei, Sawano, Mitsuaki, Ishii, Hideki, Kohsaka, Shun, Kikuta, Yuetsu, Matoba, Tetsuya, Amano, Tetsuya, and Kozuma, Ken
- Published
- 2023
- Full Text
- View/download PDF
9. Empagliflozin induces the transcriptional program for nutrient homeostasis in skeletal muscle in normal mice.
- Author
-
Kawakami, Ryo, Matsui, Hiroki, Matsui, Miki, Iso, Tatsuya, Yokoyama, Tomoyuki, Ishii, Hideki, and Kurabayashi, Masahiko
- Subjects
EXERCISE tolerance ,SODIUM-glucose cotransporter 2 inhibitors ,EMPAGLIFLOZIN ,QUADRICEPS muscle ,HOMEOSTASIS ,REGULATOR genes - Abstract
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve heart failure (HF) outcomes across a range of patient characteristics. A hypothesis that SGLT2i induce metabolic change similar to fasting has recently been proposed to explain their profound clinical benefits. However, it remains unclear whether SGLT2i primarily induce this change in physiological settings. Here, we demonstrate that empagliflozin administration under ad libitum feeding did not cause weight loss but did increase transcripts of the key nutrient sensors, AMP-activated protein kinase and nicotinamide phosphoribosyltransferase, and the master regulator of mitochondrial gene expression, PGC-1α, in quadriceps muscle in healthy mice. Expression of these genes correlated with that of PPARα and PPARδ target genes related to mitochondrial metabolism and oxidative stress response, and also correlated with serum ketone body β-hydroxybutyrate. These results were not observed in the heart. Collectively, this study revealed that empagliflozin activates transcriptional programs critical for sensing and adaptation to nutrient availability intrinsic to skeletal muscle rather than the heart even in normocaloric condition. As activation of PGC-1α is sufficient for metabolic switch from fatigable, glycolytic metabolism toward fatigue-resistant, oxidative mechanism in skeletal muscle myofibers, our findings may partly explain the improvement of exercise tolerance in patients with HF receiving empagliflozin. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
- Author
-
Ikenuma, Hiroshi, Ogata, Aya, Koyama, Hiroko, Ji, Bin, Ishii, Hideki, Yamada, Takashi, Abe, Junichiro, Seki, Chie, Nagai, Yuji, Ichise, Masanori, Minamimoto, Takafumi, Higuchi, Makoto, Zhang, Ming-Rong, Kato, Takashi, Ito, Kengo, Suzuki, Masaaki, and Kimura, Yasuyuki
- Subjects
PROTEIN kinases ,AUTORADIOGRAPHY ,PROTEIN receptors ,POSITRON emission tomography ,DRUG discovery - Abstract
Background: Receptor interacting protein kinase 1 (RIPK1) is a serine/threonine kinase, which regulates programmed cell death and inflammation. Recently, the involvement of RIPK1 in the pathophysiology of Alzheimer's disease (AD) has been reported; RIPK1 is involved in microglia's phenotypic transition to their dysfunctional states, and it is highly expressed in the neurons and microglia in the postmortem brains in AD patients. They prompt neurodegeneration leading to accumulations of pathological proteins in AD. Therefore, regulation of RIPK1 could be a potential therapeutic target for the treatment of AD, and in vivo imaging of RIPK1 may become a useful modality in studies of drug discovery and pathophysiology of AD. The purpose of this study was to develop a suitable radioligand for positron emission tomography (PET) imaging of RIPK1. Results: (S)-2,2-dimethyl-1-(5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)propan-1-one (GSK'963) has a high affinity, selectivity for RIPK1, and favorable physiochemical properties based on its chemical structure. In this study, since
11 C-labeling (half-life: 20.4 min) GSK'963 retaining its structure requiring the Grignard reaction of tert-butylmagnesium halides and [11 C]carbon dioxide was anticipated to give a low yield, we decided instead to11 C-label a GSK'963 analog ((S)-2,2-dimethyl-1-(5-(m-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)propan-1-one, GG502), which has a high RIPK1 inhibitory activity equivalent to that of the original compound GSK'963. Thus, we successfully11 C-labeled GG502 using a Pd-mediated cross-coupling reaction in favorable yields (3.6 ± 1.9%) and radiochemical purities (> 96%), and molar activity (47–115 GBq/μmol). On autoradiography, radioactivity accumulation was observed for [11 C]GG502 and decreased by non-radioactive GG502 in the mouse spleen and human brain, indicating the possibility of specific binding of this ligand to RIPK1. On brain PET imaging in a rhesus monkey, [11 C]GG502 showed a good brain permeability (peak standardized uptake value (SUV) ~3.0), although there was no clear evidence of specific binding of [11 C]GG502. On brain PET imaging in acute inflammation model rats, [11 C]GG502 also showed a good brain permeability, and no significant increased uptake was observed in the lipopolysaccharide-treated side of striatum. On metabolite analysis in rats at 30 min after administration of [11 C]GG502, ~55% and ~10% of radioactivity was from unmetabolized [11 C]GG502 in the brain and the plasma, respectively. Conclusions: We synthesized and evaluated a11 C-labeled PET ligand based on the methylated analog of GSK'963 for imaging of RIPK1 in the brain. Although in autoradiography of the resulting [11 C]GG502 indicated the possibility of specific binding, the actual PET imaging failed to detect any evidence of specific binding to RIPK1 despite its good brain permeability. Further development of radioligands with a higher binding affinity for RIPK1 in vivo and more stable metabolite profiles compared with the current compound may be required. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
11. Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
- Author
-
Ikenuma, Hiroshi, Ogata, Aya, Koyama, Hiroko, Ji, Bin, Ishii, Hideki, Yamada, Takashi, Abe, Junichiro, Seki, Chie, Nagai, Yuji, Ichise, Masanori, Minamimoto, Takafumi, Higuchi, Makoto, Zhang, Ming-Rong, Kato, Takashi, Ito, Kengo, Suzuki, Masaaki, and Kimura, Yasuyuki
- Subjects
PROTEIN kinases ,AUTORADIOGRAPHY ,PROTEIN receptors ,POSITRON emission tomography ,DRUG discovery - Abstract
Background: Receptor interacting protein kinase 1 (RIPK1) is a serine/threonine kinase, which regulates programmed cell death and inflammation. Recently, the involvement of RIPK1 in the pathophysiology of Alzheimer's disease (AD) has been reported; RIPK1 is involved in microglia's phenotypic transition to their dysfunctional states, and it is highly expressed in the neurons and microglia in the postmortem brains in AD patients. They prompt neurodegeneration leading to accumulations of pathological proteins in AD. Therefore, regulation of RIPK1 could be a potential therapeutic target for the treatment of AD, and in vivo imaging of RIPK1 may become a useful modality in studies of drug discovery and pathophysiology of AD. The purpose of this study was to develop a suitable radioligand for positron emission tomography (PET) imaging of RIPK1. Results: (S)-2,2-dimethyl-1-(5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)propan-1-one (GSK'963) has a high affinity, selectivity for RIPK1, and favorable physiochemical properties based on its chemical structure. In this study, since
11 C-labeling (half-life: 20.4 min) GSK'963 retaining its structure requiring the Grignard reaction of tert-butylmagnesium halides and [11 C]carbon dioxide was anticipated to give a low yield, we decided instead to11 C-label a GSK'963 analog ((S)-2,2-dimethyl-1-(5-(m-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)propan-1-one, GG502), which has a high RIPK1 inhibitory activity equivalent to that of the original compound GSK'963. Thus, we successfully11 C-labeled GG502 using a Pd-mediated cross-coupling reaction in favorable yields (3.6 ± 1.9%) and radiochemical purities (> 96%), and molar activity (47–115 GBq/μmol). On autoradiography, radioactivity accumulation was observed for [11 C]GG502 and decreased by non-radioactive GG502 in the mouse spleen and human brain, indicating the possibility of specific binding of this ligand to RIPK1. On brain PET imaging in a rhesus monkey, [11 C]GG502 showed a good brain permeability (peak standardized uptake value (SUV) ~3.0), although there was no clear evidence of specific binding of [11 C]GG502. On brain PET imaging in acute inflammation model rats, [11 C]GG502 also showed a good brain permeability, and no significant increased uptake was observed in the lipopolysaccharide-treated side of striatum. On metabolite analysis in rats at 30 min after administration of [11 C]GG502, ~55% and ~10% of radioactivity was from unmetabolized [11 C]GG502 in the brain and the plasma, respectively. Conclusions: We synthesized and evaluated a11 C-labeled PET ligand based on the methylated analog of GSK'963 for imaging of RIPK1 in the brain. Although in autoradiography of the resulting [11 C]GG502 indicated the possibility of specific binding, the actual PET imaging failed to detect any evidence of specific binding to RIPK1 despite its good brain permeability. Further development of radioligands with a higher binding affinity for RIPK1 in vivo and more stable metabolite profiles compared with the current compound may be required. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
12. Brugada phenocopy with altered ST-segment elevation in pericardial diffuse large B-cell lymphoma and effusive–constrictive pericarditis: a case report.
- Author
-
Ishibashi, Yohei, Zhang, Shanshan, Tamura, Shuntaro, and Ishii, Hideki
- Abstract
Background Cardiac lymphoma is a rare disease. Effusive–constrictive pericarditis can be a characteristic of pericardial involvement in patients with this disease. Conversely, a phenotype with electrocardiogram changes similar to those of Brugada syndrome is called Brugada phenocopy, and these changes improve after treatment. Case summary A 71-year-old man was transported to our hospital with chest pain, hypotension, and ST-segment elevation in V1 and V2 leads during maintenance dialysis for renal failure. After arrival at the hospital, his ST-segment elevation disappeared, and emergency coronary angiography scan revealed no significant coronary artery stenoses or obstructions. His computed tomography and echocardiography scans revealed pericardial effusion and an intrapericardial mass. Further, his blood pressure dropped and ST-segment elevation recurred during dialysis after 7 days. Thus, pericardiocentesis was performed, but haemodynamic improvement was insufficient, and right catheterization findings suggested effusive–constrictive pericarditis. Meanwhile, flow cytometry of the pericardial fluid suggested the diagnosis of B-cell lymphoma; however, radical chemoradiotherapy was impossible because of cardiogenic shock. The patient died on Day 17. Further, autopsy revealed diffuse large B-cell lymphoma with pericardial and myocardial infiltration. Discussion Cardiac lymphoma is rare but can be associated with effusive–constrictive pericarditis, which may be difficult to manage even with pericardial drainage. In such cases, radical treatment, including chemotherapy, should be promptly considered, if possible. Our patient presented with Brugada-type electrocardiogram but no syncope or family history, suggesting Brugada phenocopy and not true Brugada syndrome due to cardiac lymphoma. Notably, temporary improvement in ST-segment elevation was observed despite the absence of treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Volume-outcome relationship in complication-related mortality after percutaneous coronary interventions: an analysis on the failure-to-rescue rate in the Japanese Nationwide Registry.
- Author
-
Ando, Tomo, Yamaji, Kyohei, Kohsaka, Shun, Fukutomi, Motoki, Onishi, Takayuki, Inohara, Taku, Ishii, Hideki, Amano, Tetsuya, Ikari, Yuji, and Tobaru, Tetsuya
- Abstract
In-hospital mortality following percutaneous coronary intervention (PCI) varies across institutions with different annual PCI volumes. The failure to rescue (FTR) rate, defined as the mortality rate following PCI-related complications, may account for the volume-outcome relationship. The Japanese Nationwide PCI Registry, a consecutive, nationally mandated registry between 2019 and 2020, was queried. The FTR rate is defined as 'the number of patients who died following PCI-related complications' divided by 'the number of patients who experienced at least one PCI-related complication.' Multivariate analysis was used to calculate the risk-adjusted odds ratio (aOR) of the FTR rates among hospitals stratified into tertiles as low (≤ 236/year), medium (237–405/year), and high (≥ 406/year). A total of 465,716 PCIs and 1007 institutions were included. A volume-outcome relationship was observed for in-hospital mortality, and the medium-volume (aOR 0.90, 95% confidence interval [CI] 0.85–0.96), as well as high-volume (aOR 0.84, 95% CI 0.79–0.89) hospitals, had significantly lower in-hospital mortality than low-volume hospitals. Complication rates were lower at high-volume centers (1.9%, 2.2%, and 2.6% for high-, medium-, and low-volume centers, respectively; p < 0.001). The overall FTR rate was 19.0%. The FTR rates for the low-, medium-, and high-volume hospitals were 19.3%, 17.7%, and 20.6%, respectively. The medium-volume hospitals had a lower FTR rate (aOR 0.82, 95% [CI] 0.68–0.99), whereas the FTR rate was similar at the high-volume hospitals compared with that of the low-volume hospitals (aOR 1.02, 95% CI 0.83–1.26). In-hospital mortality was low after PCI in high-volume hospitals. However, the FTR rate in high-volume hospitals was not necessarily lower than that in low-volume hospitals. The FTR rate did not account for the volume-outcome relationship in PCI. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Diagnostic value of reduced left atrial compliance during ergometry exercise in heart failure with preserved ejection fraction.
- Author
-
Harada, Tomonari, Kagami, Kazuki, Shina, Takayuki, Sorimachi, Hidemi, Yuasa, Naoki, Saito, Yuki, Naito, Ayami, Yoshida, Kuniko, Kato, Toshimitsu, Wada, Naoki, Ishii, Hideki, and Obokata, Masaru
- Subjects
LEFT heart atrium ,VENTRICULAR ejection fraction ,SPECKLE tracking echocardiography ,ERGOMETRY ,STRESS echocardiography ,HEART failure - Abstract
Aims: Diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging in patients presenting with chronic dyspnoea. We sought to determine the diagnostic value of reduced left atrial (LA) compliance during exercise to diagnose HFpEF. Methods and results: Ergometry exercise stress echocardiography was performed in 225 patients with HFpEF and 262 non‐heart failure controls (non‐cardiac dyspnoea [NCD]) in Protocol 1, where the diagnosis of HFpEF was defined by the HFA‐PEFF algorithm. In Protocol 2, the diagnosis of HFpEF was ascertained by exercise right heart catheterization in 67 participants (49 HFpEF and 18 NCD). Speckle‐tracking echocardiography was performed at rest and during exercise to determine LA compliance (ratio of LA reservoir strain to E/e'). As compared with NCD, patients with HFpEF demonstrated decreased LA reservoir strain and compliance at rest, and these differences further increased during exercise in Protocol 1. Exercise LA compliance discriminated HFpEF from NCD (area under the curve 0.87, p < 0.0001), with a superior diagnostic ability to exercise E/e' ratio (DeLong p = 0.005). Exercise LA compliance demonstrated incremental diagnostic value over clinical factors (age, systemic hypertension, and atrial fibrillation) and resting LA compliance (χ2 212.4 vs. 166.2, p < 0.0001). These findings were confirmed in Protocol 2. Conclusion: Left atrial compliance during exercise demonstrated superior diagnostic ability to exercise E/e' ratio, with incremental diagnostic value over the resting LA compliance. Exercise LA compliance may enhance the diagnosis of HFpEF among patients with dyspnoea. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
- Author
-
Saito, Yuki, Obokata, Masaru, Harada, Tomonari, Kagami, Kazuki, Wada, Naoki, Okumura, Yasuo, and Ishii, Hideki
- Published
- 2023
- Full Text
- View/download PDF
16. Pathophysiologic Contributions of Visceral Adiposity to Left Ventricular Diastolic Dysfunction.
- Author
-
Nagata, Reika, Obokata, Masaru, Matsui, Miki, Matsui, Hiroki, Seki, Yuko, Igarashi, Takamichi, Sunaga, Hiroaki, Kawakami, Ryo, Harada, Tomonari, Kagami, Kazuki, Saeki, Hiroshi, Shirabe, Ken, Iso, Tatsuya, and Ishii, Hideki
- Published
- 2023
- Full Text
- View/download PDF
17. Small-animal PET study for noninvasive quantification of transmembrane AMPA receptor regulatory protein γ -8 (TARP γ -8) in the brain.
- Author
-
Yamasaki, Tomoteru, Ishii, Hideki, Hiraishi, Atsuto, Kumata, Katsushi, Wakizaka, Hidekatsu, Zhang, Yiding, Kurihara, Yusuke, Ogawa, Masanao, Nengaki, Nobuki, Chen, Jiahui, Li, Yinlong, Liang, Steven, and Zhang, Ming-Rong
- Abstract
Transmembrane AMPA receptor regulatory protein γ-8 (TARP γ-8) mediates various AMPA receptor functions. Recently, [
11 C]TARP-2105 was developed as a PET ligand for TARP γ-8 imaging. We performed a full kinetic analysis of [11 C]TARP-2105 using PET with [11 C]TARP-2105 for the first time. The distribution volume (VT ), which is a macro parameter consisting of the K1 – k4 rate constants in the two-tissue compartment model analysis, exhibited the following rank order: hippocampus (1.4 ± 0.3) > amygdala (1.0 ± 0.2) > frontal cortex (0.9 ± 0.2) > striatum (0.8 ± 0.2) ≫ cerebellum (0.5 ± 0.1) ≈ thalamus (0.5 ± 0.1) > pons (0.4 ± 0.1 mL/cm3 ). These heterogenous VT values corresponded with the order of biological distribution of TARP γ-8 in the brain. To validate the reference tissue model, the binding potential (BPND ) of [11 C]TARP-2105 for TARP γ-8 was estimated using general methods (SRTM, MRTM0, Logan reference model, and ratio method). These BPND s based on reference models indicated excellent correlation (R2 > 0.9) to the indirect BPND s based on 2TCM with moderate reproducibility (%variability ≈ 10). PET with [11 C]TARP-2105 enabled noninvasive BPND estimation and visual mapping of TARP γ-8 in the living rat brain. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
18. Drug-coated balloons for the treatment of stent edge restenosis.
- Author
-
Nagasaka, Takashi, Amanai, Shiro, Ishibashi, Yohei, Aihara, Kazufumi, Ohyama, Yoshiaki, Takama, Noriaki, Koitabashi, Norimichi, and Ishii, Hideki
- Published
- 2023
- Full Text
- View/download PDF
19. Disproportionate exercise‐induced pulmonary hypertension in relation to cardiac output in heart failure with preserved ejection fraction: a non‐invasive echocardiographic study.
- Author
-
Saito, Yuki, Obokata, Masaru, Harada, Tomonari, Kagami, Kazuki, Sorimachi, Hidemi, Yuasa, Naoki, Kato, Toshimitsu, Wada, Naoki, Okumura, Yasuo, and Ishii, Hideki
- Subjects
PULMONARY hypertension ,CARDIAC output ,VENTRICULAR ejection fraction ,VASCULAR remodeling ,STRESS echocardiography ,HEART failure - Abstract
Aims: Pulmonary hypertension (PH) and pulmonary vascular remodelling are common in patients with heart failure with preserved ejection fraction (HFpEF). Many patients with HFpEF demonstrate an abnormal pulmonary haemodynamic response to exercise that is not identifiable at rest. This can be estimated non‐invasively by the mean pulmonary artery pressure–cardiac output relationship (mPAP/CO slope). We sought to characterize the pathophysiology of disproportionate exercise‐induced PH in relation to CO (DEi‐PH) and its prognostic impact in patients with HFpEF. Methods and results: A total of 345 patients (166 HFpEF and 179 controls) underwent ergometry exercise stress echocardiography with simultaneous expired gas analysis. DEi‐PH was defined as the mPAP/CO slope >5.2 mmHg/L/min (median value). At rest, there were no differences in right ventricular (RV) function and severity of PH between HFpEF patients with and without DEi‐PH. Compared with controls (n = 179) and HFpEF without DEi‐PH (n = 83), HFpEF with DEi‐PH (n = 83) demonstrated worse exercise capacity (lower peak oxygen consumption), depressed RV systolic function, impaired RV–pulmonary artery coupling, limitation in CO augmentation, more right‐sided congestion, and worse ventilatory efficiency (higher minute ventilation vs. carbon dioxide volume) during peak exercise. Kaplan–Meier analyses showed that HFpEF patients with DEi‐PH had higher rates of composite outcomes of all‐cause mortality or heart failure events than those without (log‐rank p = 0.0002). Conclusion: Patients with HFpEF and DEi‐PH demonstrated distinct pathophysiologic features that become apparent only during exercise. These data suggest that DEi‐PH is a pathophysiologic phenotype of HFpEF and reinforce the importance of exercise stress echocardiography for detailed characterization of HFpEF. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Clinical implications of the cardio-ankle vascular index before and after transcatheter aortic valve implantation.
- Author
-
Miki, Yusuke, Tanaka, Akihito, Tokuda, Yoshiyuki, Tobe, Akihiro, Shirai, Yoshinori, Yuhara, Satoshi, Akita, Sho, Furusawa, Kenji, Ishii, Hideki, Mutsuga, Masato, and Murohara, Toyoaki
- Published
- 2023
- Full Text
- View/download PDF
21. Incremental diagnostic value of post-exercise lung congestion in heart failure with preserved ejection fraction.
- Author
-
Kagami, Kazuki, Obokata, Masaru, Harada, Tomonari, Sorimachi, Hidemi, Yuasa, Naoki, Saito, Yuki, Kato, Toshimitsu, Wada, Naoki, Adachi, Takeshi, and Ishii, Hideki
- Subjects
EXERCISE tests ,VENTRICULAR ejection fraction ,LUNGS ,CARDIOPULMONARY system ,CONVALESCENCE ,HEART failure - Abstract
Aims Lung ultrasound (LUS) may unmask occult heart failure with preserved ejection fraction (HFpEF) by demonstrating an increase in extravascular lung water (EVLW) during exercise. Here, we sought to examine the dynamic changes in ultrasound B-lines during exercise to identify the optimal timeframe for HFpEF diagnosis. Methods and results Patients with HFpEF (n = 134) and those without HF (controls, n = 121) underwent a combination of exercise stress echocardiography and LUS with simultaneous expired gas analysis to identify exercise EVLW. Exercise EVLW was defined by B-lines that were newly developed or increased during exercise. The E / e ′ ratio peaked during maximal exercise and immediately decreased during the recovery period in patients with HFpEF. Exercise EVLW was most prominent during the recovery period in patients with HFpEF, while its prevalence did not increase from peak exercise to the recovery period in controls. Exercise EVLW was associated with a higher E / e ′ ratio and pulmonary artery pressure, lower right ventricular systolic function, and elevated minute ventilation to carbon dioxide production (V
E vs. VCO2 ) slope during peak exercise. Increases in B-lines from rest to the recovery period provided an incremental diagnostic value to identify HFpEF over the H2 FPEF score and resting left atrial reservoir strain. Conclusion Exercise EVLW was most prominent early during the recovery period; this may be the optimal timeframe for imaging ultrasound B-lines. Exercise stress echocardiography with assessments of recovery EVLW may enhance the diagnosis of HFpEF. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
22. Diagnostic value of expired gas analysis in heart failure with preserved ejection fraction.
- Author
-
Saito, Yuki, Obokata, Masaru, Harada, Tomonari, Kagami, Kazuki, Murata, Makoto, Sorimachi, Hidemi, Kato, Toshimitsu, Wada, Naoki, Okumura, Yasuo, and Ishii, Hideki
- Subjects
RECEIVER operating characteristic curves ,GAS analysis ,OXYGEN consumption ,FRACTIONS ,VENTRICULAR ejection fraction ,HEART failure ,FAILURE analysis ,STRESS echocardiography - Abstract
Cardiopulmonary exercise testing (CPET) may potentially differentiate heart failure (HF) with preserved ejection fraction (HFpEF) from noncardiac causes of dyspnea (NCD). While contemporary guidelines for HF recommend using CPET for identifying causes of unexplained dyspnea, data supporting this practice are limited. This study aimed to determine the diagnostic value of expired gas analysis to distinguish HFpEF from NCD. Exercise stress echocardiography with simultaneous expired gas analysis was performed in patients with HFpEF (n = 116) and those with NCD (n = 112). Participants without dyspnea symptoms were also enrolled as controls (n = 26). Exercise capacity was impaired in patients with HFpEF than in controls and those with NCD, evidenced by lower oxygen consumption (VO
2 ), but there was a substantial overlap between HFpEF and NCD. Receiver operating characteristic curve analyses showed modest diagnostic abilities of expired gas analysis data in differentiating individuals with HFpEF from the controls; however, none of these variables clearly differentiated between HFpEF and NCD (all areas under the curve < 0.61). Expired gas analysis provided objective assessments of exercise capacity; however, its diagnostic value in identifying HFpEF among patients with symptoms of exertional dyspnea was modest. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
23. Evaluation and improvement of CuI‐mediated 11C‐cyanation.
- Author
-
Ishii, Hideki, Yamasaki, Tomoteru, Okamura, Toshimitsu, Zhang, Yiding, Kurihara, Yusuke, Ogawa, Masanao, Nengaki, Nobuki, and Zhang, Ming‐Rong
- Subjects
RADIOCHEMICAL purification ,POSITRON emission tomography ,PERAMPANEL ,FUNCTIONAL groups ,SMALL intestine ,HEART - Abstract
CuI‐mediated 11C‐cyanation was evaluated by synthesizing [11C]perampanel ([11C]5) as a model compound and compared with previous reports. To a DMF solution with 5′‐(2‐bromophenyl)‐1′‐phenyl‐[2,3′‐bipyridin]‐6′(1′H)‐one (4) and CuI, [11C]NH4CN in a stream of ammonia/nitrogen (5:95, v/v) gas was bubbled. Subsequently, the reaction mixture was heated at 180°C for 5 min. After HPLC purification, [11C]5 was obtained in 7.2 ± 1.0% (n = 4) non‐decay corrected radiochemical yield with >99% radiochemical purity and a molar activity of 98 ± 28 GBq/μmol. In vivo evaluations of [11C]5 were performed using small animals. PET scans to check the kinetics of [11C]5 in the whole body of mice suggested that [11C]5 spreads rapidly into the brain, heart, and lungs and then accumulates in the small intestine. To evaluate the performance of CuI‐mediated 11C‐cyanation reaction, bromobenzene (6a) was selected as the model compound; however, it failed. Therefore, optimization of the reaction conditions has been performed, and consequently, the addition of K2CO3 and prolonging the reaction time improved the radiochemical yield about double. With this improved method, CuI‐mediated 11C‐cyanation of various (hetero)aromatic bromides was performed to exhibit the tolerance of most functional groups and to provide 11C‐cyanated products in good to moderate radiochemical yields. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Safety of clinical engineer-assisted percutaneous coronary intervention.
- Author
-
Oguri, Mitsutoshi, Ishii, Hideki, Shigematsu, Takuro, Fujita, Rin, Koyama, Yuichiro, Katagiri, Takeshi, Ikai, Yoshihiro, Fujikawa, Yusuke, Takahashi, Hiroshi, Suzuki, Yoriyasu, and Murohara, Toyoaki
- Abstract
Percutaneous coronary intervention (PCI) requires multiple staff members, including interventional cardiologists, with the physical burden of heavy protective measures to minimize radiation exposure. Here, we aimed to investigate the safety of task sharing with clinical engineers (CEs) working as 1st assistant during ad hoc PCI. We retrospectively included 286 patients who underwent ad hoc PCI following diagnostic catheterization for coronary artery disease between April 2019 and March 2021. Procedural complications including coronary perforation or rupture, myocardial infarction, cerebral embolism, cardiovascular death, decreased kidney function, and radiation parameters were compared between the two clinical settings [CE group, CEs as the 1st assistant from the beginning of diagnostic coronary angiography to the end of PCI vs. doctor (DR) group, others]. There was no increase in the ratio of procedural complications in the CE group (1.7%) versus the DR group (1.2%). Fluorescence time and radiation exposure dose were significantly reduced in the CE group {25 min [interquartile range (IQR), 19–35 min] vs. 28 min (IQR, 20–39 min), P = 0.036; 908 mGy (IQR, 654–1326 mGy) vs. 1062 mGy (IQR, 732–1594 mGy), P = 0.049}. The median amount of contrast medium was significantly reduced in the CE group [100 mL (IQR, 80–119 mL) vs. 110 mL (IQR 90–140 mL), P < 0.001]. After propensity matching, fluorescence time, radiation exposure dose, and contrast medium amount were similar between groups. Task sharing with CEs as the 1st assistant during ad hoc PCI could contribute to clinical safety in patients with coronary artery disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Long‐term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve.
- Author
-
Nagasaka, Takashi, Amanai, Shiro, Ishibashi, Yohei, Aihara, Kazufumi, Ohyama, Yoshiaki, Takama, Noriaki, Koitabashi, Norimichi, and Ishii, Hideki
- Published
- 2022
- Full Text
- View/download PDF
26. Chronic left ventricular apical thrombosis complicating isolated left ventricular noncompaction in a patient with human immunodeficiency virus infection.
- Author
-
Kato, Toshimitsu, Koitabashi, Norimichi, Sano, Yukie, Yanagisawa, Kunio, Ogawa, Yoshiyuki, Saitoh, Takayuki, and Ishii, Hideki
- Published
- 2023
- Full Text
- View/download PDF
27. Impact of Hemodialysis on Clinical Outcomes in Patients Undergoing Lower Extremity Bypass Surgery for Peripheral Artery Disease—10-year Follow-Up Study.
- Author
-
Kumada, Yoshitaka, Kawai, Norikazu, Ishida, Narihiro, Mori, Akihiro, Ishii, Hideki, Ohshima, Satoru, Ito, Ryuta, Umemoto, Norio, Takahashi, Hiroshi, and Murohara, Toyoaki
- Subjects
LEG surgery ,ISCHEMIA ,CONFIDENCE intervals ,PERIPHERAL vascular diseases ,SURGERY ,PATIENTS ,VASCULAR surgery ,TREATMENT effectiveness ,DESCRIPTIVE statistics ,HEMODIALYSIS ,AMPUTATION ,LONGITUDINAL method ,PROPORTIONAL hazards models - Abstract
We investigated the clinical impact of hemodialysis on long-term outcomes of bypass surgery in patients with peripheral artery disease. We evaluated 660 consecutive patients who underwent successful bypass surgery (392 hemodialysis and 268 non-hemodialysis). The endpoint was amputation-free survival (AFS). To minimize differences in clinical characteristics between the 2 groups, propensity score matching was performed. The AFS rates for 10-year follow-up were 39.3% and 67.7% in hemodialysis and non-hemodialysis patients [hazard ratio (HR) 2.21, 95% confidence interval (CI) 1.65–3.01, P <.0001]. Cumulative incidence of amputation was higher in the hemodialysis group than in the non-hemodialysis group [(19.4 vs 8.4%, HR 2.15, 95% CI 1.29–3.74, P =.0027). In a matched cohort (n = 210 each), AFS was still lower in the hemodialysis patients (53.1 vs 66.3%, HR 1.94, 95% CI 1.36–2.82, P =.0003). However, there was no significant difference in amputation rate between the groups (10.5 vs 10.6%, HR.97, 95% CI 0.49–1.87, P =.93). In a sub-analysis of patients with critical limb ischemia, similar results were obtained. The 10-year AFS was consistently lower in the hemodialysis group than in the non-hemodialysis group. However, the amputation rate was comparable between the groups when matched for the differences in clinical characteristics. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J-PCI Registry.
- Author
-
Taku Inohara, Shun Kohsaka, Kyohei Yamaji, Osamu Iida, Toshiro Shinke, Kenichi Sakakura, Hideki Ishii, Tetsuya Amano, Yuji Ikari, Inohara, Taku, Kohsaka, Shun, Yamaji, Kyohei, Iida, Osamu, Shinke, Toshiro, Sakakura, Kenichi, Ishii, Hideki, Amano, Tetsuya, and Ikari, Yuji
- Published
- 2022
- Full Text
- View/download PDF
29. What is the mechanism of tachycardia and an apparent atrioventricular nodal response during para‐Hisian pacing?
- Author
-
Kobari, Takashi, Kaneko, Yoshiaki, Tamura, Shuntaro, Hasegawa, Hiroshi, and Ishii, Hideki
- Published
- 2022
- Full Text
- View/download PDF
30. A simple proteinuria-based risk score predicts contrast-associated acute kidney injury after percutaneous coronary intervention.
- Author
-
Fujiwara, Wakaya, Ishii, Hideki, Sobue, Yoshihiro, Shimizu, Shinya, Ishiguro, Tomoya, Yamada, Ryo, Ueda, Sayano, Nishimura, Hideto, Niwa, Yudai, Miyazaki, Akane, Miyagi, Wataru, Takahara, Shuhei, Naruse, Hiroyuki, Ishii, Junichi, Kiyono, Ken, Watanabe, Eiichi, and Izawa, Hideo
- Subjects
PERCUTANEOUS coronary intervention ,ACUTE kidney failure ,DISEASE risk factors ,CORONARY arteries ,KIDNEY diseases ,LOGISTIC regression analysis - Abstract
Contrast-associated acute kidney injury (CA-AKI) is a complication of percutaneous coronary intervention (PCI). Because proteinuria is a sentinel marker of renal dysfunction, we assessed its role in predicting CA-AKI in patients undergoing PCI. A total of 1,254 patients undergoing PCI were randomly assigned to a derivation (n = 840) and validation (n = 414) dataset. We identified the independent predictors of CA-AKI where CA-AKI was defined by the new criteria issued in 2020, by a multivariate logistic regression in the derivation dataset. We created a risk score from the remaining predictors. The discrimination and calibration of the risk score in the validation dataset were assessed by the area under the receiver-operating characteristic curves (AUC) and Hosmer–Lemeshow test, respectively. A total of 64 (5.1%) patients developed CA-AKI. The 3 variables of the risk score were emergency procedures, serum creatinine, and proteinuria, which were assigned 1 point each based on the correlation coefficient. The risk score demonstrated a good discriminative power (AUC 0.789, 95% CI 0.766–0.912) and significant calibration. It was strongly associated with the onset of CA-AKI (Cochran-Armitage test, p < 0.0001). Our risk score that included proteinuria was simple to obtain and calculate, and may be useful in assessing the CA-AKI risk before PCI. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Novel CACNA1C R511Q mutation, located in domain Ⅰ-Ⅱ linker, causes non-syndromic type-8 long QT syndrome.
- Author
-
Nakajima, Tadashi, Kawabata-Iwakawa, Reika, Tamura, Shuntaro, Hasegawa, Hiroshi, Kobari, Takashi, Itoh, Hideki, Horie, Minoru, Nishiyama, Masahiko, Kurabayashi, Masahiko, Kaneko, Yoshiaki, and Ishii, Hideki
- Subjects
CALCIUM channels ,LONG QT syndrome ,GAIN-of-function mutations - Abstract
Background: Gain-of-function mutations in CACNA1C encoding Cav1.2 cause syndromic or non-syndromic type-8 long QT syndrome (LQTS) (sLQT8 or nsLQT8). The cytoplasmic domain (D)Ⅰ-Ⅱ linker in Cav1.2 plays a pivotal role in calcium channel inactivation, and mutations in this site have been associated with sLQT8 (such as Timothy syndrome) but not nsLQT8. Objective: Since we identified a novel CACNA1C mutation, located in the DⅠ-Ⅱ linker, associated with nsLQTS, we sought to reveal its biophysical defects. Methods: Target panel sequencing was employed in 24 genotype-negative nsLQTS probands (after Sanger sequencing) and three family members. Wild-type (WT) or R511Q Cav1.2 was transiently expressed in tsA201 cells, then whole-cell Ca
2+ or Ba2+ currents (ICa or IBa ) were recorded using whole-cell patch-clamp techniques. Results: We identified two CACNA1C mutations, a previously reported R858H mutation and a novel R511Q mutation located in the DⅠ-Ⅱ linker. Four members of one nsLQTS family harbored the CACNA1C R511Q mutation. The current density and steady-state activation were comparable to those of WT-ICa . However, persistent currents in R511Q-ICa were significantly larger than those of WT-ICa (WT at +20 mV: 3.3±0.3%, R511Q: 10.8±0.8%, P<0.01). The steady-state inactivation of R511Q-ICa was weak in comparison to that of WT-ICa at higher prepulse potentials, resulting in increased window currents in R511Q-ICa . Slow component of inactivation of R511Q-ICa was significantly delayed compared to that of WT-ICa (WT-tau at +20 mV: 81.3±3.3 ms, R511Q-tau: 125.1±5.0 ms, P<0.01). Inactivation of R511Q-IBa was still slower than that of WT-IBa , indicating that voltage-dependent inactivation (VDI) of R511Q-ICa was predominantly delayed. Conclusions: Delayed VDI, increased persistent currents, and increased window currents of R511Q-ICa cause nsLQT8. Our data provide novel insights into the structure-function relationships of Cav1.2 and the pathophysiological roles of the DⅠ-Ⅱ linker in phenotypic manifestations. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
32. Diastolic Filling Time, Chronotropic Response, and Exercise Capacity in Heart Failure and Preserved Ejection Fraction With Sinus Rhythm.
- Author
-
Kazuki Kagami, Masaru Obokata, Tomonari Harada, Toshimitsu Kato, Naoki Wada, Takeshi Adachi, Hideki Ishii, Kagami, Kazuki, Obokata, Masaru, Harada, Tomonari, Kato, Toshimitsu, Wada, Naoki, Adachi, Takeshi, and Ishii, Hideki
- Published
- 2022
- Full Text
- View/download PDF
33. Discrimination of atypical atrioventricular nodal reentrant tachycardia from atrial tachycardia by the V‐A‐A‐V response.
- Author
-
Kaneko, Yoshiaki, Nakajima, Tadashi, Tamura, Shuntaro, Nagashima, Koichi, Kobari, Takashi, Hasegawa, Hiroshi, and Ishii, Hideki
- Subjects
TACHYCARDIA diagnosis ,DIFFERENTIAL diagnosis ,RETROSPECTIVE studies ,SUPRAVENTRICULAR tachycardia ,ELECTROPHYSIOLOGY ,HEART atrium ,ELECTROCARDIOGRAPHY ,SENSITIVITY & specificity (Statistics) - Abstract
Introduction: The electrophysiological discrimination between fast‐slow (F/S‐) atrioventricular (AV) nodal reentrant tachycardia (NRT) and atrial tachycardia (AT) originating from the interatrial septum remains challenging. While a V‐A‐A‐V response may occur immediately after ventricular induction or entrainment of either tachycardia, the electrophysiological dissimilarities in that response between the two tachycardias remain unclear. The purpose of this study was to identify a diagnostic indicator discriminating F/S‐AVNRT from AT by examining the difference in the V‐A‐A‐V response between the two tachycardias. Methods: This retrospective study included 17 patients with F/S‐AVNRT [seven with common‐form F/S‐AVNRT using a typical slow pathway (SP) and 10 with superior type F/S‐AVNRT using a superior SP] and 10 patients with reentrant AT. All 27 patients presented with long RP supraventricular tachycardia and an initial V‐A‐A‐V response upon ventricular induction or entrainment. The V‐A‐A‐V response in patients with F/S‐AVNRT was due to dual atrial responses. We measured the interval between the first (A1) and second atrial electrogram (A2) of V‐A‐A‐V and calculated ΔAA by subtracting A1‐A2 from the tachycardia cycle length. Results: V‐A‐A‐V responses were observed most often upon ventricular induction of F/S‐AVNRT (6 ± 5 times) as well as AT (6 ± 6 times; p =.87). The V‐A‐A‐V response upon ventricular entrainment was observed in a single patient with F/S‐AVNRT versus 10 all patients with AT (p <.001). ΔAA ranged between −80 and 228 ms in F/S‐AVNRT and between −184 and 26 ms in AT. A ΔAA > 26 ms predicted a diagnosis of F/S‐AVNRT with a 76% sensitivity and 100% specificity, while a ΔAA <−80 ms predicted a diagnosis of AT with a 50% sensitivity and 100% specificity. Conclusions: ΔAA is a useful, confirmatory, diagnostic indicator of F/S‐AVNRT versus AT associated with the V‐A‐A‐V response. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. Elevated rice 137Cs concentrations near the water inlet in paddy fields after the Fukushima nuclear accident.
- Author
-
Suzuki, Yoshimasa, Shoji, Ryosuke, Tsurumaki, Takahiro, Tamaki, Syohei, Nakashima, Kousei, Miyazu, Susumu, Yoshikawa, Natsuki, Ishii, Hideki, Nogawa, Norio, Nonaka, Masanori, Suzuki, Kazuki, and Harada, Naoki
- Subjects
CESIUM isotopes ,FUKUSHIMA Nuclear Accident, Fukushima, Japan, 2011 ,BROWN rice ,RICE ,NUCLEAR power plant accidents ,INLETS ,PADDY fields ,RICE straw - Abstract
The reasons why rice
137 Cs concentrations increase near the water inlet were investigated using rectangular experimental plots settled in paddy fields. The137 Cs concentrations in brown rice and rice straw were highest at 1 m from the inlet and decreased gradually with increasing distance, showing a negative correlation with soil exchangeable potassium content (Ex-K). The137 Cs concentration in brown rice was negatively and positively correlated with yield and sterility rate, respectively. These results suggest that soil Ex-K reduction and rice anomalies occurred near the water inlet and could contribute to the local elevation of137 Cs concentrations in rice. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
35. Comparison between biodegradable- and durable-polymer everolimus-eluting stents in hemodialysis patients with coronary artery disease.
- Author
-
Ito, Ryuta, Ishii, Hideki, Oshima, Satoru, Nakayama, Takuya, Sakakibara, Takashi, Kakuno, Motohiko, and Murohara, Toyoaki
- Abstract
To investigate the clinical outcomes after biodegradable-polymer (BP) and durable-polymer (DP) everolimus-eluting stent (EES) implantation in hemodialysis (HD) patients with coronary artery disease. We enrolled 221 consecutive HD patients successfully treated with EES implantation for coronary lesions. Over the following 2 years, we assessed the incidence of target lesion revascularization (TLR) and major adverse cardiac event (MACE), defined as the composite endpoint of TLR, all-cause mortality, or myocardial infarction. We performed a propensity-score matching analysis and collected follow-up coronary angiography data. There were 91 patients in the BP-EES group and 130 in the DP-EES group. Male sex and diabetes rates were significantly lower in the BP-EES group than in the DP-EES group. A debulking device was less frequently used in the BP-EES group than in the DP-EES group (7.6% vs. 21.5%, p = 0.006). TLR occurred in 38 patients, while stent thrombosis was observed in 3 patients; 19 patients died. TLR and MACE rates at 2 years were comparable between the two groups (19.2% in the BP-EES group vs. 20.4% in the DP-EES group, p = 0.73 and 26.9% vs. 34.2%, p = 0.93, respectively). In the propensity-score-matched cohort, TLR and MACE rates were similar between the two groups (19.2% in the BP-EES group vs. 18.1% in the DP-EES group, p = 0.69, and 26.9% vs. 30.2%, p = 0.66, respectively). Restenosis rates at follow-up angiography were similar between the two groups (p = 0.79). In hemodialysis patients, BP-EES and DP-EES showed similar 2-year clinical outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
36. Overview of in‐hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
- Author
-
Numasawa, Yohei, Inohara, Taku, Ishii, Hideki, Yamaji, Kyohei, Kohsaka, Shun, Sawano, Mitsuaki, Amano, Tetsuya, Nakamura, Masato, and Ikari, Yuji
- Published
- 2022
- Full Text
- View/download PDF
37. Right ventricular metastasis of cervical cancer visualized on transthoracic echocardiography: the importance of the "modified off-axis right ventricular apical 4-chamber view".
- Author
-
Ikoma, Takahiro, Kato, Toshimitsu, Okada, Kenya, Takama, Noriaki, Ishii, Hideki, Kimura, Takao, and Tsushima, Yoshito
- Published
- 2024
- Full Text
- View/download PDF
38. Automated radiosynthesis of [11C]MTP38—a phosphodiesterase 7 imaging tracer—using [11C]hydrogen cyanide for clinical applications.
- Author
-
Kawamura, Kazunori, Hashimoto, Hiroki, Ohkubo, Takayuki, Hanyu, Masayuki, Ogawa, Masanao, Nengaki, Nobuki, Arashi, Daisuke, Kurihara, Yusuke, Fujishiro, Tomoya, Togashi, Takahiro, Sakai, Toshiyuki, Muto, Masatoshi, Takei, Makoto, Ishii, Hideki, Saijo, Takeaki, Matsumura, Takehiko, Obokata, Naoyuki, and Zhang, Ming‐Rong
- Subjects
HYDROCYANIC acid ,CLINICAL medicine ,POSITRON emission tomography ,RADIOCHEMICAL purification ,QUALITY control - Abstract
We have developed 8‐amino‐3‐(2S,5R‐dimethyl‐1‐piperidyl)‐[1,2,4]triazolo[4,3‐a]pyrazine‐5‐[11C]carbonitrile ([11C]MTP38) as a positron emission tomography (PET) tracer for the imaging of phosphodiesterase 7. For the fully automated production of [11C]MTP38 routinely and efficiently for clinical applications, we determined the radiosynthesis procedure of [11C]MTP38 using [11C]hydrogen cyanide ([11C]HCN) as a PET radiopharmaceutical. Radiosynthesis of [11C]MTP38 was performed using an automated 11C‐labeling synthesizer developed in‐house within 40 min after the end of irradiation. [11C]MTP38 was obtained with a relatively high radiochemical yield (33 ± 5.5% based on [11C]CO2 at the end of irradiation, decay‐corrected, n = 15), radiochemical purity (>97%, n = 15), and molar activity (47 ± 12 GBq/μmol at the end of synthesis, n = 15). All the results of the quality control (QC) testing for the [11C]MTP38 injection complied with our in‐house QC and quality assurance specifications. We successfully automated the radiosynthesis of [11C]MTP38 for clinical applications using an 11C‐labeling synthesizer and sterile isolator. Taken together, this protocol provides a new radiopharmaceutical [11C]MTP38 suitable for clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
39. Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes.
- Author
-
Ando, Hirohiko, Yamaji, Kyohei, Kohsaka, Shun, Ishii, Hideki, Wada, Hideki, Yamada, Sumio, Sawano, Mitsuaki, Inohara, Taku, Numasawa, Yohei, Ikari, Yuji, and Amano, Tetsuya
- Published
- 2022
- Full Text
- View/download PDF
40. National survey of percutaneous coronary intervention during the COVID-19 pandemic in Japan: second report of the Japanese Association of Cardiovascular Intervention and Therapeutics.
- Author
-
Ishii, Hideki, Amano, Tetsuya, Kohsaka, Shun, Morino, Yoshihiro, Yokoi, Hiroyoshi, and Ikari, Yuji
- Abstract
Healthcare systems worldwide have been overburdened by the coronavirus disease 2019 (COVID-19) outbreak. Accordingly, hospitals have had to implement strategies to profoundly reorganize activities, which have affected procedures such as primary percutaneous coronary interventions (PCIs). This study aimed to describe changes in PCI practices during the health emergency at the national level. The Japanese Association of Cardiovascular Intervention and Therapeutics performed provided serial surveys of institutions throughout Japan during the pandemic. The data obtained on December, 2020 and February 2021 (during the 2nd wave of pandemic) were compared with the data obtained on August 2020 (1st wave). Primary PCI for STEMI was performed as usual in 99.1%, 98.7%, and 97.5% of institutions in mid-August, mid-December, 2020 and mid-February, 2021, respectively. The COVID-19 screening tests rates in patients were significantly higher during the third wave than during the second wave (54.0% in mid-August, 2020 and 64.6% in mid-February, 2021, P = 0.002). In addition, hospitals reported that personal protective equipment was more available over time (66.4% in mid-August, 2020 and 83.8% in mid-February, 2021, P < 0.001). In conclusion, most institutions surveyed in Japan continued to perform primary PCI as usual for STEMI patients during the second and third waves of the COVID-19 pandemic. In addition, the COVID-19 screening tests were more frequently performed over time. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons.
- Author
-
Yoshioka, Naoki, Tokuda, Takahiro, Koyama, Akio, Yamada, Takehiro, Nishikawa, Ryusuke, Shimamura, Kiyotaka, Takagi, Kensuke, Morita, Yasuhiro, Tanaka, Akihito, Ishii, Hideki, Morishima, Itsuro, and Murohara, Toyoaki
- Subjects
SURGICAL stents ,ARTERIAL diseases ,POPLITEAL artery ,ARTERIAL calcification ,PERIPHERAL vascular diseases ,CALCIPHYLAXIS - Abstract
Both polymer-coated paclitaxel-eluting stents (PC-PESs) and drug-coated balloons (DCBs) are used in conjunction with endovascular therapy (EVT) for the treatment of peripheral artery disease (PAD). We aimed to identify the risk factors for the loss of patency following the use of PC-PES and DCB in a real clinical setting. We assessed the multi-center registry data of 151 lesions from 151 patients who underwent EVT for symptomatic PAD in the superficial femoral and proximal popliteal arteries using PC-PES or DCB. One-year primary patency (PP) and clinically driven target lesion revascularization (CD-TLR) were evaluated using Kaplan–Meier analysis. The predictive risk factors for 1-year outcomes were analyzed using the random survival forest method. PC-PES and DCB were used in 65 (43.0%) and 86 (57.0%) cases, respectively. There were no significant differences in 1-year PP or freedom from CD-TLR between PC-PES and DCB. PP occurred in 85.4% and 80.2% of cases in the PC-PES and DCB groups, respectively (log-rank p = 0.65), while freedom from CD-TLR was noted in 92.7% and 94.1% of cases in the PC-PES and DCB groups, respectively (log-rank p = 0.73). In order of importance, a Clinical Frailty Scale score ≥ 6, female sex, lower proximal vessel diameter, lower body mass index, and younger and older age were identified as predictive risk factors of restenosis in the PC-PES group. Peripheral artery calcification scoring system grade of ≥ 2, post-dissection pattern ≥ D, lower proximal and distal vessel diameter, and lesion length ≥ 100 mm were identified as predictive risk factors of restenosis, in order of importance, in the DCB group. Both PC-PES and DCB were associated with favorable clinical outcomes within 1 year in patients with femoropopliteal artery disease. Furthermore, several factors that could predict restenosis within 1 year following the use of each device were detected. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. What is the mechanism of this short atrio‐His narrow QRS tachycardia?
- Author
-
Tamura, Shuntaro, Kaneko, Yoshiaki, Nakajima, Tadashi, Kobari, Takashi, Hasegawa, Hiroshi, and Ishii, Hideki
- Subjects
TACHYCARDIA diagnosis ,TACHYCARDIA treatment ,ATRIOVENTRICULAR node ,RADIO frequency therapy ,CATHETER ablation ,DIFFERENTIAL diagnosis ,ELECTROPHYSIOLOGY ,HEART atrium ,TACHYCARDIA ,ELECTROCARDIOGRAPHY ,HIS bundle - Abstract
A case study of 53-year-old woman with a history of multiple episodes of narrow QRS tachycardia underwent electrophysiological study and catheter ablation. Topics include Tachycardia with concentric atrial activation and simultaneous ventricular activation a sudden increase in the atrio-His (AH) interval during premature atrial stimulation; and diagnosis of junctional tachycardia (JT) was excluded by atrial entrainment pacing.
- Published
- 2022
- Full Text
- View/download PDF
43. Combined prognostic value of malnutrition using GLIM criteria and renal insufficiency in elderly heart failure.
- Author
-
Oguri, Mitsutoshi, Ishii, Hideki, Yasuda, Kenichiro, Sumi, Takuya, Takahashi, Hiroshi, and Murohara, Toyoaki
- Subjects
KIDNEY failure ,HEART failure patients ,MALNUTRITION - Abstract
Aims: We aimed to investigate the prognostic impact of malnutrition, defined by the Global Leadership Initiative on Malnutrition (GLIM) criteria, stratified by renal function in hospitalized patients with acute decompensated heart failure (HF). Methods and results: In this retrospective study, 314 patients who were hospitalized for acute decompensated HF from August 2019 to October 2020 were enrolled. We evaluated malnutrition using the GLIM criteria during the time of admission. The primary outcome was 90‐day all‐cause mortality. The median patient age was 82 years, and 90‐day mortality was 14.0%. In total, 76 (24.2%) patients were malnourished according to the GLIM criteria. Malnutrition defined by the GLIM criteria [adjusted hazard ratio (HR) 1.41, 95% confidence interval (CI) 1.02–1.91, P = 0.036] and renal insufficiency [adjusted HR 2.59, 95% CI 1.07–6.28, P = 0.035 for estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 vs. ≥60 mL/min/1.73 m2] were identified as independent predictors of 90‐day mortality after adjustment for age, systolic blood pressure, and serum sodium level. In the combined setting of both variables, patients with malnutrition and eGFR < 30 mL/min/1.73 m2 had a markedly higher risk of 90‐day mortality compared with those without malnutrition and eGFR ≥ 60 mL/min/1.73 m2 (adjusted HR 3.92, 95% CI 1.10–13.9, P = 0.035). Adding both eGFR and malnutrition, defined by the GLIM criteria, to the baseline model with established risk factors improved both net reclassification and integrated discrimination greater than that of the baseline model (0.606, P < 0.001 and 0.050, P = 0.002, respectively), even when compared with the model with malnutrition by the GLIM alone (0.463, P = 0.002 and 0.034, P < 0.001, respectively). Conclusions: Nutrition screening using the GLIM criteria stratified by renal function could clearly predict 90‐day mortality in hospitalized patients with acute decompensated HF. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
44. Assessment of appropriate body mass index cut-off points for long-term mortality among ST-elevation myocardial infarction survivors in Asian population using machine learning algorithm.
- Author
-
Yoshioka, Naoki, Takagi, Kensuke, Tanaka, Akihito, Morita, Yasuhiro, Yoshida, Ruka, Nagai, Hiroaki, Kanzaki, Yasunori, Watanabe, Naoki, Yamauchi, Ryota, Komeyama, Shotaro, Sugiyama, Hiroki, Shimojo, Kazuki, Imaoka, Takuro, Sakamoto, Gaku, Ohi, Takuma, Goto, Hiroki, Ishii, Hideki, Morishima, Itsuro, and Murohara, Toyoaki
- Subjects
ST elevation myocardial infarction ,BODY mass index ,ASIANS ,MACHINE learning ,PERCUTANEOUS coronary intervention - Abstract
Low body mass index (BMI) is a predictor of adverse events in patients with ST-elevated myocardial infarction (STEMI) in Western countries. Because the average BMI of Asians is significantly lower than that of the Western population, the appropriate cut-off BMI value and its role in long-term mortality are unclear in Asian patients. Between January 2006 and December 2017, 1215 patients who underwent percutaneous coronary intervention (PCI) for acute STEMI and were alive at discharge (mean age, 67.7 years; male, 75.4%) were evaluated. The cut-off BMI value, which could predict all-cause mortality within 10 years, was detected using a survival classification and regression tree (CART) model. The causes of death according to the BMI value were evaluated in each group. Based on the CART model, the patients were divided into three groups (BMI < 18 kg/m
2 : 54 patients, 18 kg/m2 ≤ BMI ≤ 20 kg/m2 : 109 patients, and BMI > 20 kg/m2 : 1052 patients). The BMI decreased with age; with an increased BMI, patients with dyslipidemia, diabetes mellitus, and smoking habit increased. During the study period (median, 4.9 years), 194 patients (26.8%) died (cardiac death, 59 patients; non-cardiac death, 135 patients). All-cause mortality was more frequent as the BMI decreased (BMI < 18 kg/m2 ; 72.8%, 18 kg/m2 ≤ BMI ≤ 20 kg/m2 ; 40.5%, and BMI > 20 kg/m2 ; 22.8%; log-rank p < 0.001). Non-cardiac deaths were more frequent than cardiac deaths in all groups, and the dominance of non-cardiac death was highest in the lowest BMI group. Cut-off BMI values of 18 kg/m2 and 20 kg/m2 can predict long-term mortality after PCI in Asian STEMI survivors, whose cut-off value is lower than that in the Western populations. The main causes of death in this cohort differed according to the BMI values. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
45. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.
- Author
-
Ozaki, Yukio, Hara, Hironori, Onuma, Yoshinobu, Katagiri, Yuki, Amano, Tetsuya, Kobayashi, Yoshio, Muramatsu, Takashi, Ishii, Hideki, Kozuma, Ken, Tanaka, Nobuhiro, Matsuo, Hitoshi, Uemura, Shiro, Kadota, Kazushige, Hikichi, Yutaka, Tsujita, Kenichi, Ako, Junya, Nakagawa, Yoshihisa, Morino, Yoshihiro, Hamanaka, Ichiro, and Shiode, Nobuo
- Abstract
Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018. Updated guidelines for the management of AMI were published by the European Society of Cardiology (ESC) in 2017 and 2020. Major changes in the guidelines for STEMI patients included: (1) radial access and drug-eluting stents (DES) over bare-metal stents (BMS) were recommended as a Class I indication, (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. In 2020, updated guidelines for Non-ST-Elevation Myocardial Infarction (NSTEMI) patients, the followings were changed: (1) an early invasive strategy within 24 h is recommended in patients with NSTEMI as a Class I indication, (2) complete revascularization in NSTEMI patients without cardiogenic shock is considered as Class IIa recommendation, and (3) in patients with atrial fibrillation following a short period of triple antithrombotic therapy, dual antithrombotic therapy (e.g., DOAC and single oral antiplatelet agent preferably clopidogrel) is recommended, with discontinuation of the antiplatelet agent after 6 to 12 months. Furthermore, an aspirin-free strategy after PCI has been investigated in several trials those have started to show the safety and efficacy. The Task Force on Primary PCI of the CVIT group has now proposed the updated expert consensus document for the management of AMI focusing on procedural aspects of primary PCI in 2022 version. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
46. Variation in in-hospital mortality and its association with percutaneous coronary intervention-related bleeding complications: A report from nationwide registry in Japan.
- Author
-
Sawayama, Yuichi, Yamaji, Kyohei, Kohsaka, Shun, Yamamoto, Takashi, Higo, Yosuke, Numasawa, Yohei, Inohara, Taku, Ishii, Hideki, Amano, Tetsuya, Ikari, Yuji, and Nakagawa, Yoshihisa
- Subjects
HOSPITAL mortality ,HEMORRHAGE ,PERCUTANEOUS coronary intervention ,BLOOD transfusion ,ODDS ratio - Abstract
Large-scale registries have demonstrated that in-hospital mortality after percutaneous coronary intervention (PCI) varies widely across institutions. However, whether this variation is related to major procedural complications (e.g., bleeding) is unclear. In this study, institutional variation in in-hospital mortality and its association with PCI-related bleeding complications were investigated. We analyzed 388,866 procedures at 718 hospitals performed from 2017 to 2018, using data from a nationwide PCI registry in Japan. Hospitals were stratified into quintiles according to risk-adjusted in-hospital mortality (very low, low, medium, high, and very high). Incidence of bleeding complications, defined as procedure-related bleeding events that required a blood transfusion, and in-hospital mortality in patients who developed bleeding complications were calculated for each quintile. Overall, 4,048 (1.04%) in-hospital deaths and 1,535 (0.39%) bleeding complications occurred. Among patients with bleeding complications, 270 (17.6%) died during hospitalization. In-hospital mortality ranged from 0.22% to 2.46% in very low to very high mortality hospitals. The rate of bleeding complications varied modestly from 0.27% to 0.57% (odds ratio, 1.95; 95% confidence interval, 1.58–2.39). However, mortality after bleeding complications markedly increased by quintile and was 6-fold higher in very high mortality hospitals than very low mortality hospitals (29.0% vs. 4.8%; odds ratio, 12.2; 95% confidence interval, 6.90–21.7). In conclusion, institutional variation in in-hospital mortality after PCI was associated with procedure-related bleeding complications, and this variation was largely driven by differences in mortality after bleeding complications rather than difference in their incidence. These findings underscore the importance of efforts toward reducing not only bleeding complications but also, even more importantly, subsequent mortality once they have occurred. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
47. Incidental findings on computed tomography for preoperative assessment before transcatheter aortic valve implantation in Japanese patients.
- Author
-
Tobe, Akihiro, Tanaka, Akihito, Tokuda, Yoshiyuki, Miki, Yusuke, Furusawa, Kenji, Akita, Sho, Fujii, Taro, Tsutsumi, Yoshinori, Ishii, Hideki, Iwano, Shingo, Naganawa, Shinji, Usui, Akihiko, and Murohara, Toyoaki
- Subjects
HEART valve prosthesis implantation ,COMPUTED tomography ,JAPANESE people ,MORTALITY - Abstract
Extra-cardiovascular incidental findings (IFs) on preoperative computed tomography (CT) are frequently observed in transcatheter aortic valve implantation (TAVI) candidates. However, the backgrounds of TAVI candidates and comorbidities differ based on the race and/or country, and data on IFs in a specific population are not always applicable to another. The aim of this study was to assess the prevalence, type, and clinical impact of IFs in Japanese TAVI candidates. This was a retrospective, single-center, observational study. CT reports of 257 TAVI candidates were reviewed, and IFs were classified as (a) insignificant: findings that did not require further investigation, treatment, or follow-up; (b) intermediate: findings that needed to be followed up or were considered for further investigation but did not affect the planning of TAVI; and (c) significant: findings that required further investigation immediately or affected the planning of TAVI. At least one IF was found in 254 patients (98.8%). Insignificant, intermediate, and significant IFs were found in 253 (98.4%), 153 (59.5%), and 34 (13.2%) patients, respectively. Newly indicated significant IFs were found in 19 patients (7.4%). In 2 patients (0.8%), TAVI was canceled because of significant IFs. In patients who consequently underwent TAVI, the presence of significant IFs was not associated with the duration from CT performance to TAVI [28 (19–40) days vs. 27 (19–43) days, p = 0.74] and all-cause mortality during the median follow-up period of 413 (223–805) days (p = 0.44). Almost all Japanese TAVI candidates had at least one IF, and the prevalence of significant IFs was not negligible. Although the presence of significant IFs was not associated with mid-term mortality, appropriate management of IFs was considered important. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. Pacing site‐ and rate‐dependent shortening of retrograde conduction time over the slow pathway after atrial entrainment of fast‐slow atrioventricular nodal reentrant tachycardia.
- Author
-
Kaneko, Yoshiaki, Nakajima, Tadashi, Tamura, Shuntaro, Hasegawa, Hiroshi, Kobari, Takashi, and Ishii, Hideki
- Subjects
ATRIOVENTRICULAR node ,CARDIOVASCULAR system physiology ,VENTRICULAR tachycardia ,ELECTROPHYSIOLOGY ,ELECTRIC stimulation ,DESCRIPTIVE statistics - Abstract
Introduction: We tested our hypothesis that atrial entrainment pacing (EP) of a) the common‐type (com‐) fast‐slow (F/S‐) atypical atrioventricular nodal reentrant tachycardia (AVNRT) using a typical slow pathway (SP), or b) the superior‐type (sup‐) F/S‐AVNRT using a superior SP, both modify the retrograde conduction time across the SP immediately after termination of EP (retro‐SP‐time). Methods: We measured the difference in the His‐atrial interval (HA difference) immediately after cessation of EP, performed at 2 ± 2 rates from the high right atrium (HA[1]‐HRA) versus from the proximal coronary sinus (HA[1]‐CS) in 17 patients with com‐F/S‐AVNRT and 11 patients with sup‐F/S‐AVNRT. We also measured the atrial‐His and HA intervals of the first and second cycles immediately after cessation of EP and during stable tachycardia. Results: Unequal responses, defined as a ≥ 20‐ms HA difference at ≥1 EP rates, were observed in 16 patients (57%), including 7 with com‐ and 9 with sup‐F/S‐AVNRT. Irrespective of the EP rate, all unequal responses of com‐F/S‐AVNRT were due to a shorter HA[1]‐CS than HA[1]‐HRA, with a mean 34 ± 11 ms HA difference, whereas all unequal responses of sup‐F/S‐AVNRT were due to a longer HA[1]‐CS than HA[1]‐HRA, with a mean 49 ± 25 ms HA difference. The unequal responses resolved within two cycles after the cessation of EP. Conclusions: We have identified a little‐known pacing site‐ and pacing rate‐dependent shortening of the retro‐SP‐time. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
49. Outcomes after drug-coated balloon interventions for de novo coronary lesions in the patients on chronic hemodialysis.
- Author
-
Ito, Ryuta, Ishii, Hideki, Oshima, Satoru, Nakayama, Takuya, Sakakibara, Takashi, Kakuno, Motohiko, and Murohara, Toyoaki
- Subjects
ATHERECTOMY ,HEMODIALYSIS patients ,CORONARY artery bypass ,HEMODIALYSIS ,CORONARY artery disease ,ENDARTERECTOMY - Abstract
The impact of drug-coated balloon (DCB) on hemodialysis (HD) patients with coronary lesions remains unclear. This study aimed to compare outcomes after DCB treatment between HD and non-HD patients with de novo coronary lesions. A total of 235 consecutive patients who electively underwent DCB treatment for de novo coronary lesions were included (HD group: n = 100; non-HD group: n = 135). Angiographic follow-up was performed 6 months after the procedure. Patients were clinically followed up for 2 years. The incidence rates of target lesion revascularization (TLR) and major adverse cardiac events (MACE) were investigated. Diabetes and a history of coronary bypass grafting were more frequent in the HD group than in the non-HD group (69.0% vs. 50.7%, p = 0.007, and 24.0% vs 9.1%, p = 0.013, respectively). The reference diameter and pre-procedural diameter stenosis were greater in the HD group than in the non-HD group (2.49 mm vs. 2.24 mm, p = 0.007, and 65.9% vs. 59.6%, p = 0.015, respectively). Calcification was observed in 65.5% of all lesions, and rotational atherectomy was performed in 30.2% patients. The average diameter of the DCB was 2.51 mm (2.57 mm, HD group vs. 2.47 mm, non-HD group, p = 0.14). Although post-procedural diameter stenosis was similar between the groups, late lumen loss on follow-up angiography was larger in HD patients than in non-HD patients (0.27 mm vs. − 0.03 mm, p = 0.0009). The 2-year rates of freedom from TLR and MACE were lower in HD patients than in non-HD patients [79.3% vs. 91.7%, hazard ratio (HR) 2.76, 95% confidence interval (CI) 1.23–6.77, p = 0.014; and 61.6% vs. 89.4%, HR 4.60, 95% CI 2.30–10.2, p < 0.001, respectively]. In conclusion, the rates of TLR and MACE after DCB treatment were higher in HD patients than in non-HD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
50. Radiocaesium accumulation in rice cultivars in a low-potassium paddy field in Fukushima.
- Author
-
Gong, Siyu, Ishii, Hideki, and Nemoto, Keisuke
- Subjects
NUCLEAR power plant accidents ,RICE ,CULTIVARS ,BROWN rice ,PADDY fields ,RICE processing - Abstract
The accumulation of radiocaesium in the grains of 15 rice cultivars was monitored in 2014 and 2015. The study area was a local paddy field with low soil potassium concentrations, where highly radiocaesium contaminated rice had been commercially harvested because of the Fukushima Daiichi Nuclear Power Plant accident. The concentrations of radiocaesium in the resulting brown rice were all high, ranging from 150 to 960 Bq kg
−1 (decay-corrected to December 2011), and the transfer factors were approximately 10- to 25-fold higher than those of previous studies. In this study, the trend of radiocaesium accumulation in each of the improved indica, aus, and japonica cultivars became clear, whereas none of the previous studies showed a clear trend in each cultivar group. The high radiocaesium accumulation in improved indica cultivars (e.g. Takanari) should be taken into account when considering the expansion of rice cultivation for processing and forage. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.